International Cooperation · 3.5 Regional Collaboration on Drug Policies

Partially meets the criterion.

Mexico has clear evidence of participation in regional drug-policy monitoring mechanisms. Mexico’s evaluation under CICAD/OAS’s Multilateral Evaluation Mechanism establishes that the country is part of a hemispheric system for regional monitoring and evaluation. This is the core source for the indicator because it documents Mexico-specific regional monitoring. In addition, CONASAMA’s national report on mental health and substance use shows domestic information-production capacity, while the National Research Priorities Agenda and the FIAP/COPOLAD III source provide complementary evidence on research, observatories, technical cooperation, and early warning.

However, the available evidence does not confirm a specific operational regional agreement, signed or formally binding, with verifiable national implementation obligations for Mexico. The reviewed sources establish regional participation, hemispheric evaluation, and strengthened national monitoring capacity, but they do not fully verify an operational regional agreement with traceable national commitments, compliance follow-up, and verifiable results. Therefore, the criterion is partially met: regional monitoring and technical articulation exist, but documentary evidence of an operational regional agreement with verifiable national obligations remains missing.